Table 1.
SYNJ1 in human Alzheimer’s disease: genetic association, neuropathology and expression in human brains.
| Populations | Genetic Association of SYNJ1
|
Human Brains
|
||
|---|---|---|---|---|
|
| ||||
| - | Neuropathology | SYNJ1 RNA | SYNJ1 Protein | |
|
| ||||
| Late Onset AD (LOAD) | Not detected [42–46] | Accumulation in plaque-associated dystrophic neurites, in Hirano bodies and in some neurofibrillary tangles [60] Co-precipitation with (PHF)-tau [60] |
Transcriptomics: decreased in LOAD (AD Knowledge Portal) [55–57] Increased in LOAD, correlate with levels of phosphorylated tau [60] |
Proteomics: increased [58] or decreased (AD Knowledge Portal) [59] in LOAD Increased in detergent-insoluble fraction in LOAD, correlate with levels of phosphorylated tau [60] Decreased in total homogenate and detergent-soluble fraction in LOAD [60, 62]. Within the LOAD cohort, APOE4 carriers have higher SYNJ1 levels than non-carriers [60] |
| Increased [64] or unchanged [60] in APOE4 carriers in a control cohort | Increased in APOE4 carriers in a control cohort [64] | |||
| Increased in APOE4 carriers with early LOAD (CDR 0.5–1) [64] and late-stage LOAD (Braak V-VI) [60] miR-195 levels reduced in APOE4 carriers with MCI and early LOAD (CDR 0.5–1), but unchanged in normal aging (CDR 0) or at advanced stages (CDR 3) [69] |
Increased in cases with early LOAD (CDR 0.5–1), unchanged at advanced stages (CDR 3) [64] | |||
|
| ||||
| High Risk Down Syndrome (DS) | Unexplored | Inverse correlation with synaptophysin levels among older individuals with DS-AD [52] | Increased in DS vs. disomic controls [68] | Increased in DS vs. disomic controls [60, 62, 66, 67] |
|
| ||||
| High Risk Autosomal Dominant AD (ADAD) | Yes, early- and late-onset [52] | Co-precipitation with (PHF)-tau [60] | Similar to LOAD (small sample size) [60] | Similar to LOAD (small sample size) [60] |
Abbreviations: PHF, paired helical filaments, CDR, clinical dementia rating, miR, microRNA, MCI, mild cognitive impairment.
Icons were generated with biorender.com.